Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Hangzhou, Zhejiang, China.
Clin Implant Dent Relat Res. 2023 Oct;25(5):910-918. doi: 10.1111/cid.13223. Epub 2023 May 26.
The aim of this study was to evaluate the efficacy of endoscope-controlled sinus floor augmentation through a mini-lateral window, compared with traditional lateral window approach.
This retrospective research included 19 patients and 20 augmented sinuses using lateral window approach with simultaneous implant placement (test group: a 3-4 mm round osteotomy; control group: a 10 × 8 mm rectangular osteotomy). Preoperatively (T0), immediately after surgery (T1), and 6 months postoperatively (T2), cone-beam computed tomography (CBCT) scans were obtained. Residual bone height (RBH), lateral window dimension (LWD), endo-sinus bone gain (ESBG), apical bone height (ABH), and bone density were measured. Intraoperative and postoperative complications were recorded. Patients' evaluation of pain first day after surgery and a week later was assessed by visual analog scale (VAS).
No significant difference was found in ESBG, ABH between the two groups at T1, T2 or their changes from T1 to T2. However, the increase of bone density value in the test group was significantly higher than control group (356.28 ± 149.59 vs. 242.99 ± 129.54; p < 0.05). The sinus perforation rate of test and control group was 10% and 20%, respectively. The VAS score of the test group at the first day after surgery was significantly lower than control group (4.20 ± 1.03 vs. 5.60 ± 1.71; p < 0.05).
Endoscope-controlled maxillary sinus floor augmentation through a mini-lateral window yield similar result with traditional approach in terms of bone height gain. The modified approach could facilitate new bone formation, reducing sinus perforation rate and postoperative pain.
本研究旨在评估经小侧窗内镜控制下鼻窦底提升术的疗效,并与传统的侧窗入路进行比较。
本回顾性研究纳入了 19 名患者的 20 个接受侧窗入路同期植入的鼻窦(实验组:3-4mm 圆形截骨;对照组:10×8mm 矩形截骨)。术前(T0)、术后即刻(T1)和术后 6 个月(T2)时,进行锥形束 CT(CBCT)扫描。测量剩余骨高度(RBH)、侧窗宽度(LWD)、窦内骨增量(ESBG)、根尖骨高度(ABH)和骨密度。记录术中及术后并发症。采用视觉模拟评分(VAS)评估患者术后第 1 天和第 1 周的疼痛。
两组在 T1、T2 时的 ESBG 和 ABH 无显著差异,从 T1 到 T2 的变化也无显著差异。然而,实验组的骨密度值增加明显高于对照组(356.28±149.59 比 242.99±129.54;p<0.05)。实验组和对照组的窦穿孔率分别为 10%和 20%。实验组术后第 1 天的 VAS 评分明显低于对照组(4.20±1.03 比 5.60±1.71;p<0.05)。
经小侧窗内镜控制上颌窦底提升术与传统方法在骨高度增加方面具有相似的效果。改良方法可以促进新骨形成,降低窦穿孔率和术后疼痛。